Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2010 Dec 10:11:120.
doi: 10.1186/1745-6215-11-120.

The fitness for the Ageing Brain Study II (FABS II): protocol for a randomized controlled clinical trial evaluating the effect of physical activity on cognitive function in patients with Alzheimer's disease

Elizabeth V Cyarto  1 , Kay L Cox, Osvaldo P Almeida, Leon Flicker, David Ames, Gerard Byrne, Keith D Hill, Christopher D Beer, Dina LoGiudice, Kana Appadurai, Muireann Irish, Emma Renehan, Nicola T Lautenschlager
Affiliations
Randomized Controlled Trial

The fitness for the Ageing Brain Study II (FABS II): protocol for a randomized controlled clinical trial evaluating the effect of physical activity on cognitive function in patients with Alzheimer's disease

Elizabeth V Cyarto et al. Trials. .

Abstract

Background: Observational studies have documented a potential protective effect of physical exercise in older adults who are at risk for developing Alzheimer's disease. The Fitness for the Ageing Brain II (FABS II) study is a multicentre randomized controlled clinical trial (RCT) aiming to determine whether physical activity reduces the rate of cognitive decline among individuals with Alzheimer's disease. This paper describes the background, objectives of the study, and an overview of the protocol including design, organization and data collection methods.

Methods/design: The study will recruit 230 community-dwelling participants diagnosed with Alzheimer's disease. Participants will be randomly allocated to two treatment groups: usual care group or 24-week home-based program consisting of 150 minutes per week of tailored moderate physical activity. The primary outcome measure of the study is cognitive decline as measured by the change from baseline in the total score on the Alzheimer's disease Assessment Scale-Cognitive section. Secondary outcomes of interest include behavioral and psychological symptoms, quality of life, functional level, carer burden and physical function (strength, balance, endurance, physical activity). Primary endpoints will be measured at six and twelve months following the baseline assessment.

Discussion: This RCT will contribute evidence regarding the potential benefits of a systematic program of physical activity as an affordable and safe intervention for people with Alzheimer's disease. Further, if successful, physical activity in combination with usual care has the potential to alleviate the symptoms of Alzheimer's disease and improve its management and the quality of life of patients and their carers.

Trial registration: Australia New Zealand Clinical Trials Registry ACTRN12609000755235.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Study Design.
See this image and copyright information in PMC

References

    1. Jorm AF. In: Principles and practice of geriatric psychiatry. 2. Copeland JRM, Abou-Saleh MT, Blazer DG, editor. Chichester: Wiley; 2002. Dementia epidemiology: prevalence and incidence; pp. 195–197. full_text.
    1. Alzheimer's Disease International. World Alzheimer Report 2009. London: Alzheimer's Disease International; 2009.
    1. McKhann G, Drachman D, Folstein MF, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34(7):939–944. - PubMed
    1. Rabins PV, Lyketsos CG. Cholinesterase inhibitors and memantine have a role in the treatment of Alzheimer's disease. Nat Clin Pract Neurol. 2006;2(11):578–579. doi: 10.1038/ncpneuro0269. - DOI - PubMed
    1. Middleton LE, Yaffe K. Promising strategies for the prevention of dementia. Arch Neurol. 2009;66(10):1210–1215. doi: 10.1001/archneurol.2009.201. - DOI - PMC - PubMed

Publication types